Clinical Trial Update: A Two Part Trial Investigating an Anti-obesity Drug in Overweight/Obese Male and Female Healthy Volunteers [Phase 1]

View source ↗

Summary

A Phase 1 trial of an anti-obesity drug sponsored by Novo Nordisk A/S in overweight/obese healthy volunteers was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Metabolism and Nutrition Disorder, Obesity | Phase 1 | Status: TERMINATED